150 related articles for article (PubMed ID: 31731188)
1. PSA targeted dual-modality manganese oxide-mesoporous silica nanoparticles for prostate cancer imaging.
Du D; Fu HJ; Ren WW; Li XL; Guo LH
Biomed Pharmacother; 2020 Jan; 121():109614. PubMed ID: 31731188
[TBL] [Abstract][Full Text] [Related]
2. Manganese-impregnated mesoporous silica nanoparticles for signal enhancement in MRI cell labelling studies.
Guillet-Nicolas R; Laprise-Pelletier M; Nair MM; Chevallier P; Lagueux J; Gossuin Y; Laurent S; Kleitz F; Fortin MA
Nanoscale; 2013 Dec; 5(23):11499-511. PubMed ID: 24178890
[TBL] [Abstract][Full Text] [Related]
3. Structure-property relationships in manganese oxide--mesoporous silica nanoparticles used for T1-weighted MRI and simultaneous anti-cancer drug delivery.
Chen Y; Chen H; Zhang S; Chen F; Sun S; He Q; Ma M; Wang X; Wu H; Zhang L; Zhang L; Shi J
Biomaterials; 2012 Mar; 33(7):2388-98. PubMed ID: 22177841
[TBL] [Abstract][Full Text] [Related]
4. Enriching Mn-Doped ZnSe Quantum Dots onto Mesoporous Silica Nanoparticles for Enhanced Fluorescence/Magnetic Resonance Imaging Dual-Modal Bio-Imaging.
Zhou R; Sun S; Li C; Wu L; Hou X; Wu P
ACS Appl Mater Interfaces; 2018 Oct; 10(40):34060-34067. PubMed ID: 30211537
[TBL] [Abstract][Full Text] [Related]
5. In Vivo Dual-Modality Fluorescence and Magnetic Resonance Imaging-Guided Lymph Node Mapping with Good Biocompatibility Manganese Oxide Nanoparticles.
Zhan Y; Zhan W; Li H; Xu X; Cao X; Zhu S; Liang J; Chen X
Molecules; 2017 Dec; 22(12):. PubMed ID: 29231865
[TBL] [Abstract][Full Text] [Related]
6. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
[TBL] [Abstract][Full Text] [Related]
7. Ternary-Responsive Drug Delivery with Activatable Dual Mode Contrast-Enhanced in Vivo Imaging.
Ren S; Yang J; Ma L; Li X; Wu W; Liu C; He J; Miao L
ACS Appl Mater Interfaces; 2018 Sep; 10(38):31947-31958. PubMed ID: 30179443
[TBL] [Abstract][Full Text] [Related]
8. Mesoporous manganese silicate coated silica nanoparticles as multi-stimuli-responsive T1-MRI contrast agents and drug delivery carriers.
Li X; Zhao W; Liu X; Chen K; Zhu S; Shi P; Chen Y; Shi J
Acta Biomater; 2016 Jan; 30():378-387. PubMed ID: 26602820
[TBL] [Abstract][Full Text] [Related]
9. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells.
Chen Y; Yin Q; Ji X; Zhang S; Chen H; Zheng Y; Sun Y; Qu H; Wang Z; Li Y; Wang X; Zhang K; Zhang L; Shi J
Biomaterials; 2012 Oct; 33(29):7126-37. PubMed ID: 22789722
[TBL] [Abstract][Full Text] [Related]
10. Predictable Heating and Positive MRI Contrast from a Mesoporous Silica-Coated Iron Oxide Nanoparticle.
Hurley KR; Ring HL; Etheridge M; Zhang J; Gao Z; Shao Q; Klein ND; Szlag VM; Chung C; Reineke TM; Garwood M; Bischof JC; Haynes CL
Mol Pharm; 2016 Jul; 13(7):2172-83. PubMed ID: 26991550
[TBL] [Abstract][Full Text] [Related]
11. Gd-Al co-doped mesoporous silica nanoparticles loaded with Ru(bpy)₃²⁺ as a dual-modality probe for fluorescence and magnetic resonance imaging.
Zhang D; Gao A; Xu Y; Yin XB; He XW; Zhang YK
Analyst; 2014 Sep; 139(18):4613-9. PubMed ID: 25046328
[TBL] [Abstract][Full Text] [Related]
12. Microwave-Synthesized Platinum-Embedded Mesoporous Silica Nanoparticles as Dual-Modality Contrast Agents: Computed Tomography and Optical Imaging.
Chu CH; Cheng SH; Chen NT; Liao WN; Lo LW
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925712
[TBL] [Abstract][Full Text] [Related]
13. Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells.
Kim T; Momin E; Choi J; Yuan K; Zaidi H; Kim J; Park M; Lee N; McMahon MT; Quinones-Hinojosa A; Bulte JW; Hyeon T; Gilad AA
J Am Chem Soc; 2011 Mar; 133(9):2955-61. PubMed ID: 21314118
[TBL] [Abstract][Full Text] [Related]
14. Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy.
Cai X; Zhu Q; Zeng Y; Zeng Q; Chen X; Zhan Y
Int J Nanomedicine; 2019; 14():8321-8344. PubMed ID: 31695370
[TBL] [Abstract][Full Text] [Related]
15. In vivo tumor vasculature targeted PET/NIRF imaging with TRC105(Fab)-conjugated, dual-labeled mesoporous silica nanoparticles.
Chen F; Nayak TR; Goel S; Valdovinos HF; Hong H; Theuer CP; Barnhart TE; Cai W
Mol Pharm; 2014 Nov; 11(11):4007-14. PubMed ID: 24937108
[TBL] [Abstract][Full Text] [Related]
16. Functional mesoporous silica nanoparticles for bio-imaging applications.
Cha BG; Kim J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jan; 11(1):e1515. PubMed ID: 29566308
[TBL] [Abstract][Full Text] [Related]
17. PEG-coated and Gd-loaded fluorescent silica nanoparticles for targeted prostate cancer magnetic resonance imaging and fluorescence imaging.
Jiang W; Fang H; Liu F; Zhou X; Zhao H; He X; Guo D
Int J Nanomedicine; 2019; 14():5611-5622. PubMed ID: 31413566
[No Abstract] [Full Text] [Related]
18. Detection of glutathione based on MnO
Tan Q; Zhang R; Kong R; Kong W; Zhao W; Qu F
Mikrochim Acta; 2017 Dec; 185(1):44. PubMed ID: 29594599
[TBL] [Abstract][Full Text] [Related]
19. Mn(2+)-doped silica nanoparticles for hepatocyte-targeted detection of liver cancer in T1-weighted MRI.
Kim SM; Im GH; Lee DG; Lee JH; Lee WJ; Lee IS
Biomaterials; 2013 Nov; 34(35):8941-8. PubMed ID: 23973173
[TBL] [Abstract][Full Text] [Related]
20. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
